Overview

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to demonstrate the bioequivalence (BE) of two alprazolam 1 mg tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Alprazolam